StockTipsArenaBeta

BUY Glenmark Pharmaceuticals — Osho Krishan, Angel One

BUYGlenmark Pharmaceuticals
Glenmark Pharmaceuticals share price target & all analyst calls

byOsho Krishan, Angel OneHorizon: NA (inferred Swing (≤2wk))7 Jul 2026via NDTV Profit (Live)

Entry₹2,270.9Stated
Target₹2,350
Total upside +3.48% (call closed)
Stop loss₹2,200-3.12% risk
At expiry₹2,239.620 Jul 2026, 3:30 pm
Expired-1.38%
Follow Osho Krishan for new calls(29% target hit, 165 closed calls)Get alertsWatch GLENMARK for new buy/sell callsGet alertsSee 1 active Swing call on GLENMARKSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 20 Jul 2026
3 supporting0 opposing
Supports the BUY call (3)

Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection, 10 mg/vial, Single-Dose Vial.

NSE · Press Release·6 Jul · 2w ago

(opens in new tab)

Glenmark Pharmaceuticals Ltd is advancing its Multi-Country Phase 3 Clinical Trial of Trastuzmab rezetecan in Platinum-Resistant Ovarian Cancer.

BSE · Company Update·2 Jul · 3w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·29 Jun · 3w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Glenmark Pharmaceuticals

All analyst calls on Glenmark Pharmaceuticals

More from Osho Krishan, Angel One

Every call and its outcome